The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents

Cutis

Volumn 64, Issue 6, 1999, Pages 407-410

  Mehregan, Darius R ^b,c   Gee, Susanne L ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pinkus Dermatopathology Laboratory   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ECONOMICS; HUMAN; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; ITRACONAZOLE; NAPHTHALENES; ONYCHOMYCOSIS;

EID: 0033257462     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mehregan DA, Mehregan DR, Rinker A: Onychomycosis. Cutis 59: 247-248, 1997.
2. Elewski BE: Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 35: S6-S9, 1996.
3. Pierard GE, Arrese JE, De Doncker P, et al.: Present and potential diagnostic techniques in Onychomycosis. J Am Acad Dermatol 34: 273-277, 1996.
4. Leyden J: Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol 38: S42-S47, 1998.
5. nd ed. Philadelphia; WB Saunders Co., 1997.
6. Bootman JL: Cost-effectiveness of two new treatments for onychomycosis. An analysis of two comparative clinical trials. J Am Acad Dermatol 38: S69-S71, 1998.
7. Brautigam M: Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails. J Am Acad Dermatol 38: S53-S56, 1998.
8. De Backer M, De Vroey C, Lesaffre E, et al.: Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes. J Am Acad Dermatol 38: S57-S63, 1998.
9. De Doncker P, Decrois J, Pierard GE, et al.: Antifungal pulse therapy for onychomycosis. Arch Dermatol 1: 34-41, 1996.
10. Evans EGV: Causative pathogens in onychomycosis and the possibility of treatment resistance: a review. J Am Acad Dermatol 38: S32-S36, 1998.
11. Katz HI: Systemic antifungal agents used to treat onychomycosis. J Am Acad Dermatol 38: S48-S52, 1998.
12. Arenas R, Dominques-Cherit J, Fernandez LM: Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 34: 138-143, 1995.
13. Brautigam M, Nolting S, Schopf RE, et al.: Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Brit Med J 311:919-922, 1995.
14. st ed. Philadelphia, WB Saunders, 1991.